JP2025515091A5 - - Google Patents
Info
- Publication number
- JP2025515091A5 JP2025515091A5 JP2024564919A JP2024564919A JP2025515091A5 JP 2025515091 A5 JP2025515091 A5 JP 2025515091A5 JP 2024564919 A JP2024564919 A JP 2024564919A JP 2024564919 A JP2024564919 A JP 2024564919A JP 2025515091 A5 JP2025515091 A5 JP 2025515091A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- eye
- pharmaceutical composition
- composition according
- cfi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263338392P | 2022-05-04 | 2022-05-04 | |
| US63/338,392 | 2022-05-04 | ||
| PCT/US2023/066620 WO2023215840A1 (en) | 2022-05-04 | 2023-05-04 | Complement factor i dosing regimens for treating ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515091A JP2025515091A (ja) | 2025-05-13 |
| JP2025515091A5 true JP2025515091A5 (cg-RX-API-DMAC7.html) | 2026-05-14 |
Family
ID=86760162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564919A Pending JP2025515091A (ja) | 2022-05-04 | 2023-05-04 | 眼疾患を治療するための補体因子i投与レジメン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250177482A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4518881A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025515091A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250008764A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119698286A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023265150A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3251504A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316772A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202400627A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023215840A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3117551A1 (en) * | 2018-10-23 | 2020-04-30 | Gemini Therapeutics Inc. | Compositions and methods for treating age-related macular degeneration and other diseases |
| GB201821082D0 (en) * | 2018-12-21 | 2019-02-06 | Gyroscope Therapeutics Ltd | Combination of complement factors i and h, and vector encoding thereof |
| WO2021257480A2 (en) * | 2020-06-14 | 2021-12-23 | Catalyst Biosciences, Inc. | Complement factor i-related compositions and methods |
-
2023
- 2023-05-04 EP EP23730321.9A patent/EP4518881A1/en active Pending
- 2023-05-04 AU AU2023265150A patent/AU2023265150A1/en active Pending
- 2023-05-04 JP JP2024564919A patent/JP2025515091A/ja active Pending
- 2023-05-04 CA CA3251504A patent/CA3251504A1/en active Pending
- 2023-05-04 IL IL316772A patent/IL316772A/en unknown
- 2023-05-04 KR KR1020247040205A patent/KR20250008764A/ko active Pending
- 2023-05-04 CN CN202380045885.4A patent/CN119698286A/zh active Pending
- 2023-05-04 TW TW112116648A patent/TW202400627A/zh unknown
- 2023-05-04 WO PCT/US2023/066620 patent/WO2023215840A1/en not_active Ceased
-
2024
- 2024-11-01 US US18/935,289 patent/US20250177482A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9044436B2 (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| US9662371B2 (en) | Treatment of autism and similar disorders | |
| JP2015520188A5 (cg-RX-API-DMAC7.html) | ||
| JP2020524139A5 (cg-RX-API-DMAC7.html) | ||
| JP2016514132A5 (cg-RX-API-DMAC7.html) | ||
| WO2021021931A1 (en) | Materials and methods for treating friedreich's ataxia | |
| CN119421702A (zh) | 替尔泊肽组合物和用途 | |
| CA2032859C (en) | Method of reducing or preventing adverse effect of steroid therapy and compositions therefor | |
| EP1846022B1 (en) | Methods for treating adhesive capsulitis | |
| CN112888453A (zh) | 用于治疗再生障碍性贫血的药物组合物 | |
| US11033607B2 (en) | Peptides and methods for preventing ischemic tissue injury | |
| JP2019504007A (ja) | 糖尿病を治療するための医薬製剤 | |
| JP2023551193A (ja) | 抗体関連型拒絶反応を処置するための方法 | |
| US20240424055A1 (en) | Administration of c5-binding proteins | |
| CN118973600A (zh) | 用于脐带血移植后的血细胞恢复的药物组合物 | |
| JPH03291236A (ja) | 感作t細胞関与疾患の治療剤 | |
| JP7621411B2 (ja) | 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品 | |
| Ciulla et al. | Avacincaptad pegol. Complement C5 inhibitor, Treatment of geographic atrophy secondary to dry age-related macular degeneration, Treatment of Stargardt disease | |
| Wong | What's new in contemporary ophthalmic drug delivery systems: Understanding the latest innovative technologies. | |
| TW202535943A (zh) | 改善抗FcRn療法之方法 | |
| HUP9901774A2 (hu) | II Típusú kollagént tartalmazó gyógyszerkészítmények reumaszerű ízületi gyulladás kezelésére | |
| Syringe | DIAPER RASH | |
| Capsules | NEW DRUG APPROVALS | |
| Kobayashi et al. | WSAAI 50th Annual Scientific Session, Kohala Coast, Hawaii, January 20–24, 2013 | |
| IL266163B2 (en) | Pharmaceutical composition and method of treating female sexual dysfunctions |